We are live on ! Find out more
MGRM

Monogram Orthopaedics
MGRM

Delisted

MGRM was delisted on the 6th of October, 2025.

Back to rankings

18 hedge funds and large institutions have $1.03M invested in Monogram Orthopaedics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

238% more capital invested

Capital invested by funds: $305K → $1.03M (+$724K)

38% more funds holding

Funds holding: 13 → 18 (+5)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

1.09% more ownership

Funds ownership: 0.26% → 1.35% (+1.1%)

Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FPAS
Focus Partners Advisor Solutions
Missouri
+$847K
2
Millennium Management
Millennium Management
New York
+$478K
3
BlackRock
BlackRock
New York
+$20.8K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$11.1K
5
Osaic Holdings
Osaic Holdings
Arizona
+$9.18K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$16.2K
2
TPCW
TD Private Client Wealth
New York
-$14K
3
Morgan Stanley
Morgan Stanley
New York
-$7.58K
4
TFA
Toth Financial Advisory
Virginia
-$278

MGRM Hedge Fund Activity: Q3 2023 in Review

18 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Monogram Orthopaedics (MGRM) for Q3 2023, worth a combined $1.03M — up 238% from $305K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MGRM positions and 1 closed out — a net gain of 5 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Focus Partners Advisor Solutions, opening a new position worth an estimated $847K. The largest seller was UBS Group, cutting an estimated $16.2K.

  • 18 institutional investors held Monogram Orthopaedics (MGRM) as of Q3 2023, up from 13 in Q2 2023.
  • Funds reported $1.03M of Monogram Orthopaedics stock for Q3 2023, up 238% quarter-over-quarter.
  • 6 funds opened new Monogram Orthopaedics positions in Q3 2023 and 1 closed out, a net change of +5 holders.
  • The largest Monogram Orthopaedics buyer in Q3 2023 was Focus Partners Advisor Solutions, an estimated $847K added.
  • The largest Monogram Orthopaedics seller in Q3 2023 was UBS Group, an estimated $16.2K sold.

Based on aggregated 13F filings for Q3 2023.